Literature DB >> 15793714

Remission induced by interferon alfa in a patient with massive osteolysis and extension of lymph-hemangiomatosis: a severe case of Gorham-Stout syndrome.

Atsushi Takahashi1, Chitose Ogawa, Takashi Kanazawa, Hideomi Watanabe, Makoto Suzuki, Norio Suzuki, Yoshiaki Tsuchida, Akihiro Morikawa, Hiroyuki Kuwano.   

Abstract

The treatment of massive osteolysis with lymphangioma and/or hemangioma (Gorham-Stout syndrome) has been controversial. The authors report on a patient with multiple massive osteolyses and extensive lymph-hemangiomatosis whose lesions were reduced by interferon alfa therapy. A 2-year-old girl had complained of left chylothorax. Thoracoscopy showed an increase in small lymphatic vessels in the chest wall. The chylothorax was improved by coagulation of the lymphatic vessels. Later, multiple massive osteolyses appeared in the left 11th and 12th ribs, the TH10-L3 vertebrae, and the right femur. There were also hemangiomas in the liver and spleen, a tumor lesion in the left lower chest wall, and hemangiomatous change on the skin surface of the left back. The left lung had only a minimal air content. After OK-432 was injected into the femur and chest wall lesions, the femur lesion disappeared. Then, as right chylothorax appeared, OK-432 was injected into the right pulmonary cavity. The chylothorax disappeared, but pericardial effusion appeared. After steroid pulse therapy, pericardial effusion disappeared. During these treatments, the 7th to 10th ribs disappeared from the x-ray and scoliosis developed. One month later, a cloudy fluid collection in the right lung was found on computed tomography. Interferon alfa and steroid pulse therapy were started. Interferon alfa (1,500,000 units) was subcutaneously administered daily for 2 months and was gradually reduced and maintained at 1,500,000 unit/wk. Steroids were also reduced and maintained at 5 mg/d of predonine. Later, the progress of osteolysis and the extension of lymph-hemangiomatosis stopped. Ten months later, hemangioma in the back disappeared, and the 7th to 10th ribs, which had disappeared, reappeared. The interferon alfa therapy was stopped 14 months after it was administered. The patient's condition has been stable for 10 months since then. At this time, computed tomography shows regression of the hemangiomatous lesion in the back. The authors clinically diagnosed the patient as having Gorham-Stout syndrome with extension of lymph-hemangiomatosis. Interferon alfa with or without steroid therapy should be a choice for patients with extension lesions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15793714     DOI: 10.1016/j.jpedsurg.2004.11.015

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  24 in total

1.  Gorham-Stout syndrome with chylothorax in a six-year-old boy.

Authors:  Murat Deveci; Nagihan Inan; Funda Corapçıoğlu; Gülşen Ekingen
Journal:  Indian J Pediatr       Date:  2010-12-25       Impact factor: 1.967

Review 2.  Tonsillar herniation spectrum: more than just Chiari I. Update and controversies on classification and management.

Authors:  Pietro Fiaschi; Giovanni Morana; Pasquale Anania; Andrea Rossi; Alessandro Consales; Gianluca Piatelli; Armando Cama; Marco Pavanello
Journal:  Neurosurg Rev       Date:  2019-11-10       Impact factor: 3.042

3.  Management of a pathological fracture in a rare case of Gorham Stout disease of the hip with a mega prosthesis.

Authors:  Raju Vaishya; Abhishek Vaish; Lokesh Kumar Singh; Pankaj Baweja
Journal:  J Orthop       Date:  2019-08-21

4.  Intraosseous CSF fistula in a patient with Gorham disease resulting in intracranial hypotension.

Authors:  F Adler; N Gupta; C P Hess; C F Dowd; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-09       Impact factor: 3.825

5.  Thoracic osteotomy for Gorham-Stout disease of the spine: a case report and literature review.

Authors:  C Maillot; T Cloche; J-C Le Huec
Journal:  Eur Spine J       Date:  2014-10-21       Impact factor: 3.134

6.  Two cases of Gorham-Stout disease with good response to zoledronic acid treatment.

Authors:  María Lorena Brance; Alejandro Castiglioni; Nicolas Cóccaro; Mariano Palatnik
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

7.  Gorham-Stout syndrome of the pelvic girdle treated by radiation therapy: a case report.

Authors:  Reinhard Heyd; Daniela Rabeneck; Oliver Dörnenburg; Nikolaos Tselis; Nikolaos Zamboglou
Journal:  Strahlenther Onkol       Date:  2011-01-18       Impact factor: 3.621

Review 8.  Novel molecular pathways in Gorham disease: implications for treatment.

Authors:  Jeroen Hagendoorn; Torunn I Yock; Inne H M Borel Rinkes; Timothy P Padera; David H Ebb
Journal:  Pediatr Blood Cancer       Date:  2013-11-08       Impact factor: 3.167

9.  Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009.

Authors:  Sébastien Héritier; Martine Le Merrer; Francis Jaubert; Michèle Bigorre; Marion Gillibert-Yvert; Benoit de Courtivron; Makram Ziade; Yves Bertrand; Christian Carrie; Pascal Chastagner; Cécile Bost-Bru; Jean-Claude Léonard; Marie Ouache; Liliane Boccon-Gibod; Pierre Mary; Jacques de Blic; Isabelle Pin; Daniel Wendling; Yann Revillon; Véronique Houdoin; Véronique Forin; Hubert Ducou Lepointe; Jane Languepin; Jeanne Wagnon; Ralph Epaud; Brigitte Fauroux; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2010-02-03       Impact factor: 4.123

Review 10.  Gorham-Stout syndrome in mainland China: a case series of 67 patients and review of the literature.

Authors:  Po Hu; Xiang-gui Yuan; Xin-yang Hu; Fa-rong Shen; Jian-an Wang
Journal:  J Zhejiang Univ Sci B       Date:  2013-08       Impact factor: 3.066

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.